Grindr is looking for something serious

You probably know Grindr—the place to find a date, fling, or midnight hookup. But the company behind the LGBTQ+ dating app wants to be more than a matchmaker.

Grindr is expanding beyond dating into healthcare after it agreed to acquire PurposeMed, the parent of HIV-prevention telehealth provider Freddie, for $250 million. Freddie will join Grindr’s existing Woodwork telehealth service under the broader Grindr Health umbrella.

Grindr will pay $190 million in cash and $60 million in stock, with another $70 million potentially coming Freddie’s way if it hits certain performance targets in 2027.

A surprisingly good match

On paper, healthcare and dating apps might look like an odd match, which may help explain why shares fell 8.28% today. In practice, there are some—much as it pains us to say it—very real synergies.

Freddie is focused largely on PrEP, a medication that can reduce the risk of getting HIV by as much as 99%, and its platform has served more than 55,000 patients across the US and Canada.

Grindr, meanwhile, has nearly 16 million monthly users—and a direct line to many of the customers Freddie is trying to reach. Grindr estimates that about 2.2 million Americans could benefit from PrEP, but only about 650,000 currently use it.

Freddie expects more than $80 million in revenue and $10 million in adjusted EBITDA this year, and Grindr projects that annual revenue from the deal could reach $240 million.

Playing the long game

Healthcare may seem like an unusual side quest for a dating app, but branching out could help it stay ahead as competition for users intensifies.

In addition to the new revenue stream Freddie offers, the company is also testing Edge, a premium tier that has been priced as high as $80 a week and is expected to be the company’s biggest revenue growth driver in 2027. Dating giant Match Group, Grindr’s closest competitor and the owner of Tinder and Hinge, gets roughly 98% of its revenue from premium tools.

If Edge takes off, it can add another growth engine to an already strong business: Grindr’s second-quarter revenue jumped 33% to $138 million, while average paying users climbed 16% to 1.4 million. Meanwhile, Match’s paid user base fell 6% over the same period.

Following the announcement, Citizens reiterated its Market Outperform rating and $21 price target, pointing to potential revenue synergies between Freddie and Grindr. Morgan Stanley is also bullish on the stock, with an Overweight rating and $20 price target, though its latest note predates the deal.

Compared to Match, Grindr is still the smaller name—but it’s giving investors more reasons to swipe right. For an app built around short-term connections, this stock may be worth sticking around for.—SY